Sun Phar­ma, Taro Phar­ma­ceu­ti­cal reach $75M set­tle­ment agree­ment in al­leged price fix­ing scheme

The In­di­an multi­na­tion­al drug­mak­er Sun Phar­ma, along­side Is­rael’s Taro Phar­ma­ceu­ti­cal In­dus­tries, is cash­ing out tens of mil­lions to set­tle a law­suit in a US fed­er­al court.

In a mo­tion dat­ed Thurs­day, fed­er­al judge Cyn­thia M. Rufe out of Penn­syl­va­nia’s east­ern dis­trict signed off on a set­tle­ment that would re­solve an­titrust lit­i­ga­tion in­volv­ing Sun Phar­ma and Taro Phar­ma­ceu­ti­cals. The eight-page or­der de­tailed that the val­ue was set for $75 mil­lion, with the chance for an­oth­er $20 mil­lion to be added based on spe­cif­ic claus­es in the set­tle­ment agree­ment.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN